CD81 is a candidate tumor suppressor gene in human gastric cancer

Cellular Oncology

Volumn 36, Issue 2, 2013, Pages 141-153

  Yoo, Tae Hyoung ^a   Ryu, Byung Kyu ^a   Lee, Min Goo ^a   Chi, Sung Gil ^a  

^a Korea University   (South Korea)

Author keywords

Apoptosis; CD81; Cell proliferation; Gastric cancer; Promoter hypermethylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; MESSENGER RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CD81 GENE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRESS; CPG ISLAND; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENOME; HUMAN; HUMAN TISSUE; METHYLATION; PRIMARY TUMOR; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GENE; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANTIGENS, CD81; APOPTOSIS; AZACITIDINE; BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84876476630     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0119-z     Document Type: Article

References (36)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, 2012. CA Cancer J. Clin. 61(69-90) (2011)
2. R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29 (2012)
3. H.T. Lynch, W. Grady, G. Suriano, D. Huntsman, Gastric cancer: new genetic developments. J. Surg. Oncol. 90, 114-133 (2005)
4. K.W. Jung, S. Park, Y.J. Won, H.J. Kong, J.Y. Lee, H.G. Seo, J.S. Lee, Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res. Treat. 44, 25-31 (2012)
5. W. Yasui, K. Sentani, N. Sakamoto, K. Anami, Y. Naito, N. Oue, Molecular pathology of gastric cancer: research and practice. Pathol. Res. Pract. 207, 608-612 (2011)
6. S. David, S.J. Meltzer, Stomach-Genetic and epigenetic alterations of preneoplastic and neoplastic lesions. Cancer Biomark. 9, 493-507 (2010)
7. S. Wittmann, B. Zirn, M. Alkassar, P. Ambros, N. Graf, M. Gessler, Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis. Gene. Chromosome. Canc. 46, 163-170 (2007)
8. E.F. Attiyeh, W.B. London, Y.P. Mosse, Q. Wang, C. Winter, D. Khazi, P.W. McGrady, R.C. Seeger, A.T. Look, H. Shimada, G.M. Brodeur, S.L. Cohn, K.K. Matthay, J.M. Maris, Children's Oncology group, chromosome 1p and 11q deletions and outcome in neuroblastoma. N. Engl. J. Med. 353, 2243-2253 (2005)
9. N. Chunder, S. Mandal, A. Roy, S. Roychoudhury, C.K. Panda, Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival. Diagn. Mol. Pathol. 13, 172-182 (2004)
10. D. Roy, G. Calaf, T.K. Hei, Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int. J. Cancer 103, 730-737 (2003)
11. Y.K. Tran, I.F. Newsham, High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res. 56, 2916-2921 (1996)
12. J.H. Lichy, M. Zavar, M.M. Tsai, T.J. O'Leary, J.K. Taubenberger, Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast. Am. J. Pathol. 153, 271-278 (1998)
13. E. Rodriguez, P.H. Rao, M. Ladanyi, N. Altorki, A.P. Albino, D.P. Kelsen, S.C. Jhanwar, R.S. Chaganti, 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res. 50, 6410-6416 (1990)
14. A.S. Yustein, J.C. Harper, G.R. Petroni, O.W. Cummings, C.A. Moskaluk, S.M. Powell, Allelotype of gastric adenocarcinoma. Cancer Res. 59, 1437-1441 (1999)
15. R. Baffa, M. Negrini, B. Mandes, M. Rugge, G.N. Ranzani, S. Hirohashi, C.M. Croce, Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56, 268-272 (1996)
16. J.H. Lee, D.S. Byun, M.G. Lee, B.K. Ryu, M.J. Kang, K.S. Chae, K.Y. Lee, H.J. Kim, H. Park, S.G. Chi, Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. Int. J. Cancer 122, 1573-1584 (2008)
17. J.H. Lee, M.J. Kang, H.Y. Han, M.G. Lee, S.I. Jeong, B.K. Ryu, T.K. Ha, N.G. Her, J. Han, S.J. Park, K.Y. Lee, H.J. Kim, S.G. Chi, Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis. Clin. Cancer Res. 17, 7551-7562 (2011)
18. R. Oren, S. Takahashi, C. Doss, R. Levy, S. Levy, TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10, 4007-4015 (1990)
19. S. Levy, S.C. Todd, H.T. Maecker, CD 81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89-109 (1998)
20. M.E. Hemler, Tetraspanin fuctions and associated microdomains. Nat. Rev. Cell Biol. 6, 801-811 (2005)
21. M. Mittelbrunn, M. Yáñez-Mó, D. Sancho, A. Ursa, F. Sánchez-Madrid, Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 15, 6691-6695 (2002)
22. M.L. Andria, C.L. Hsieh, R. Oren, U. Francke, S. Levy, Genomic organization and chromosomal localization of the TAPA-1 gene. J. Immunol. 147, 1030-1036 (1991)
23. K.I. Virtaneva, N. Emi, J.S. Marken, A. Aruffo, C. Jones, N.K. Spurr, J.P. Schroder, Chromosomal localization of three human genes coding for A15, L6, and S5.7 (TAPA1): all members of the transmembrane 4 superfamily of proteins. Immunogenetics 39, 329-334 (1994)
24. T. Muzzafar, L.J. Medeiros, S.A. Wang, A. Brahmandam, D.A. Thomas, J.L. Jorgensen, Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry. Am. J. Clin. Pathol. 132, 692-698 (2009)
25. R.F. Luo, S. Zhao, R. Tibshirani, J.H. Myklebust, M. Sanyal, R. Fernandez, D. Gratzinger, R.J. Marinelli, Z.S. Lu, A. Wong, R. Levy, S. Levy, Y. Natkunam, CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Hum. Pathol. 41, 271-280 (2010)
26. M. Zoller, Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 9, 40-55 (2009)
27. M.J. Kang, B.K. Ryu, M.G. Lee, J.H. Han, J.H. Lee, T.K. Ha, D.S. Byun, K.S. Chae, B.H. Lee, H.S. Chun, K.Y. Lee, H.J. Kim, S.G. Chi, NF-κB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology 135, 2030-2042 (2008)
28. J.H. Kim, T. Takahashi, I. Chiba, J.G. Park, M.J. Birrer, J.K. Roh, H. Lee, J.P. Kim, J.D. Minna, A.F. Gazdar, Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J. Natl. Canc. Inst. 83, 938-943 (1991)
29. H. Yokozaki, Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol. Int. 50, 767-777 (2000)
30. M.O. Hiltunen, J. Koistinaho, L. Alhonen, S. Myöhänen, S. Marin, V.M. Kosma, M. Pääkkönen, J. Jänne, Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. Br. J. Cancer 76, 1124-1130 (1997)
31. A. Vincent, M. Perrais, J.L. Desseyn, J.P. Aubert, P. Pigny, I. Van Seuningen, Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 26, 6566-6576 (2007)
32. V. Carloni, A. Mazzocca, T. Mello, A. Galli, S. Capaccioli, Cell fusion promotes chemoresistance in metastatic colon carcinoma. Oncogene (2012) Epub ahead of print
33. B. Paiva, N.C. Gutiérrez, X. Chen, M.B. Vídriales, M.A. Montalbán, L. Rosiñol, A. Oriol, J. Martínez-López, M.V. Mateos, L. López-Corral, E. Díaz-Rodríguez, J.J. Pérez, E. Fernández-Redondo, F. de Arriba, L. Palomera, E. Bengoechea, M.J. Terol, R. de Paz, A. Martin, J. Hernández, A. Orfao, J.J. Lahuerta, J. Bladé, A. Pandiella, J.F. Miguel, Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. Leukemia 26, 1862-1869 (2012)
34. H. Rubibfeld, R. Seger, The ERK cascade: a prototype of MAPK signaling. Mol. Biotech. 31, 151-174 (2005)
35. V. Carloni, A. Massocca, K.S. Ravichandran, Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene 23, 1566-1574 (2004)
36. M. Lishner, V. Zismanov, T. Tohami, S. Tartakover-Matalon, A. Elis, L. Drucker, Tetraspanins affect myeloma cell fate via Akt signaling and FoxO activation. Cell. Signal. 20, 2309-2316 (2008)